Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

Detalles Bibliográficos
Autores principales: Jones, Trace M., Espitia, Claudia, Wang, Wei, Nawrocki, Steffan T., Carew, Jennifer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842502/
https://www.ncbi.nlm.nih.gov/pubmed/31706349
http://dx.doi.org/10.1186/s40880-019-0418-0
_version_ 1783468053733834752
author Jones, Trace M.
Espitia, Claudia
Wang, Wei
Nawrocki, Steffan T.
Carew, Jennifer S.
author_facet Jones, Trace M.
Espitia, Claudia
Wang, Wei
Nawrocki, Steffan T.
Carew, Jennifer S.
author_sort Jones, Trace M.
collection PubMed
description
format Online
Article
Text
id pubmed-6842502
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68425022019-11-12 Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies Jones, Trace M. Espitia, Claudia Wang, Wei Nawrocki, Steffan T. Carew, Jennifer S. Cancer Commun (Lond) Research Highlight BioMed Central 2019-11-09 /pmc/articles/PMC6842502/ /pubmed/31706349 http://dx.doi.org/10.1186/s40880-019-0418-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Highlight
Jones, Trace M.
Espitia, Claudia
Wang, Wei
Nawrocki, Steffan T.
Carew, Jennifer S.
Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
title Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
title_full Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
title_fullStr Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
title_full_unstemmed Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
title_short Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
title_sort moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor roc-325 shows significant potential in preclinical studies
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842502/
https://www.ncbi.nlm.nih.gov/pubmed/31706349
http://dx.doi.org/10.1186/s40880-019-0418-0
work_keys_str_mv AT jonestracem movingbeyondhydroxychloroquinethenovellysosomalautophagyinhibitorroc325showssignificantpotentialinpreclinicalstudies
AT espitiaclaudia movingbeyondhydroxychloroquinethenovellysosomalautophagyinhibitorroc325showssignificantpotentialinpreclinicalstudies
AT wangwei movingbeyondhydroxychloroquinethenovellysosomalautophagyinhibitorroc325showssignificantpotentialinpreclinicalstudies
AT nawrockisteffant movingbeyondhydroxychloroquinethenovellysosomalautophagyinhibitorroc325showssignificantpotentialinpreclinicalstudies
AT carewjennifers movingbeyondhydroxychloroquinethenovellysosomalautophagyinhibitorroc325showssignificantpotentialinpreclinicalstudies

Ejemplares similares